Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that ...

A groundbreaking discovery led scientists to create a world's first - a drug that can reverse the signs of biological aging.

The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

In many ways, these are the best of times for Silicon Valley’s buzziest crop of longevity startups and their pursuit of drugs ...

Researchers developed an OSK therapy that can partially reset epigenetic aging in optic neurons. Preclinical data ...

Over the past three decades, the field of aging research has made substantial strides, reaching a stage where we now possess a basic understanding of the underlying mechanisms that drive the aging ...

As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...